Pitfalls in interpretation of clinical trials

Abemaciclib plus trastuzumab fulvestrant increased OS for HR+, HER2+ advanced breast cancer

Value based care with a focus on education

Challenges to developing the quality of complex cancer surgery in LMICs

Early palliative care in India

Trials in LMIC and HIC – are the standards applicable globally ?

The concept of time toxicity: A patient's perspective

Interpreting statistics in clinical trials

Value based care with a focus on education

Defining value based care for LMICs

Choosing the control arm/standard of care in clinical trials

Choosing Wisely and the National Cancer grid efforts in reducing low value cancer care in India